Quince Therapeutics (QNCX) rated Buy ahead of Phase 3 NEAT readout in A-T; eDSP targets $1B+ orphan market with strong cash ...

The FDA has granted an in-person Type C meeting during the first quarter of 2026 New independent analyses across large observational ALS cohorts ...

Survival is not a victory parade; it is a long-term contract with chronic illness.

SAN FRANCISCO -- Patients with colorectal cancer (CRC) had significantly less fatigue and better quality of life (QoL) when ...

Men with newly diagnosed multiple myeloma are twice as likely as women to have stage III disease, with more kidney damage and ...

The American College of Cardiology issued its inaugural JACC Cardiovascular Statistics report, highlighting the prevalence of ...

Research from Oregon Health & Science University has found that laws restricting access to abortion may disproportionately ...

The annual report covers the five most impactful cardiovascular diseases, aiming for accountability and action.

Drugs like Ozempic have transformed how we treat obesity, but a review of almost 40 studies shows it doesn't take long for ...

The ROAR trial tested the hypothesis that returning familial hypercholesterolemia-associated genetic results leads to ...

Genmab shifts to innovation-led growth with 21% revenue, 52% operating profit, $3.4B cash, Epkinly, Rina-S, and Anthropic AI ...

The American College of Cardiology found uneven gains and sobering declines in heart health. "You can't treat your way out of ...